DBV Technologies S.A. - ADR

$16.61

up-down-arrow $-0.97 (-5.52%)

As on 05-Jun-2026 13:39EDT

Market cap

info icon

$1,130 Mln

Revenue (TTM)

info icon

$0 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

5.4

Div. Yield

info icon

0 %

DBV Technologies S.A. - ADR Share Price

Compare

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 16.41 High: 17.26

52 Week Range

Low: 8.30 High: 26.19

Liquidityliquidity Moderate

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    $0 Mln

  • ROEROE information

    -1.6 %

  • ROCEROCE information

    -- %

  • Industry P/EIndustry P/E information

    --

  • EV/EBITDAEV/EBITDA information

    -2.1

  • Debt to EquityDebt to Equity information

    0

  • Book ValueBook Value information

    $--

  • EPSEPS information

    $-1.9

  • Face valueFace value information

    --

  • Shares outstandingShares outstanding information

    59,186,456

10 Years Aggregate

CFO

$-963.47 Mln

EBITDA

$-1,132.99 Mln

Net Profit

$-1,164.09 Mln

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
DBV Technologies S.A. - ADR
-13.4 -14.7 -27.1 104.1 -5.8 -21.4 -25.9
BSE Sensex
-12.3 -3.9 -6.2 -8.3 5.9 7.3 10.7
S&P Small-Cap 600#
-5.8 -5.3 -13.7 -6.3 5.3 3.0 5.5
As on 05-Jun-2026  |  #As on 26-Oct-2023
Company
2025
2024
2023
2022
2021
2020
2019
DBV Technologies S.A. - ADR
520.4 -67.3 -37.7 -4.4 -38.9 -75.5 66.7
S&P Small-Cap 600
4.0 7.0 13.9 -17.4 25.3 9.6 20.9
BSE Sensex
9.1 8.1 18.7 4.4 22.0 15.8 14.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price ($) Market Cap ($ Mln) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
DBV Technologies S.A. - ADR
16.6 1,130.5 0.0 -167.9 -- -128.7 -- 5.4
3.1 354.2 68.1 -67.3 -104.0 -83.9 -- 6.1
28.1 1,862.3 1,043.8 488.8 -19.0 16 3.2 0.5
25.0 16,164.9 8,837.9 2,614.3 36.5 45.7 20.1 2.8
4.1 157.5 0.0 -72.1 -- -88 -- 1.8
12.9 917.4 106,763.2 5,307.0 5.8 2147 68.4 3.4
3.0 641.2 4.0 -198.4 -5,037.7 -166.3 -- 8.0
6.2 325.9 0.8 -75.0 -8,478.9 -121.5 -- 6.6
5.5 592.7 156.3 -138.0 -16.7 -121.5 -- 6.7
16.7 2,074.6 453.3 -178.1 -38.4 -25.1 -- 3.2

Shareholding Pattern

View Details
loading...
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

About DBV Technologies S.A. - ADR

DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France. Its product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed...  Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of immunoglobulin E (IgE) mediated or cow's milk protein allergy and eosinophilic esophagitis. The company's earlier stage research programs include celiac disease. In addition, the company develops Viaskin technology platform, a platform to potentially treat food allergy. It has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Châtillon, France.  Read more

Edit peer-selector-edit
loading...
loading...

FAQs for DBV Technologies S.A. - ADR

The share price of DBV Technologies SA - ADR is $16.61 (NASDAQ) as of 05-Jun-2026 13:39 EDT. DBV Technologies SA - ADR has given a return of -5.85% in the last 3 years.

Since, TTM earnings of DBV Technologies SA - ADR is negative, P/E ratio is not available.
The P/B ratio of DBV Technologies SA - ADR is 5.43 times as on 29-May-2026, a 0 premium to its peers’ median range of 5.43 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2025
-9.99
8.70
2024
-0.52
2.17
2023
-1.26
0.65
2022
-1.49
0.74
2021
-0.90
0.89

The 52-week high and low of DBV Technologies SA - ADR are Rs 26.19 and Rs 8.30 as of 06-Jun-2026.

DBV Technologies SA - ADR has a market capitalisation of $ 1,130 Mln as on 29-May-2026. As per SEBI classification, it is a Small Cap company.

Before investing in DBV Technologies SA - ADR, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.